Leung K K, Visser D W
J Biol Chem. 1977 Apr 25;252(8):2492-7.
Three mutants of Escherichia coli B which are defective in components of the transport system for uridine and uracil were isolated and utilized to study the mechanism of uridine transport. Mutant U- was isolated from a culture resistant to 77 micronM 5-fluorouracil. Mutant U-UR-, isolated from a culture of mutant U-, is resistant to 770 micronM 5-fluorouracil and 750 micronM adenosine. Mutant NUC- is resistant to 80 micronM showdomycin and has been reported previously. The characteristics of uridine transport by E. coli B and the mutants provide data supporting the following conclusions. The transport of adenosine, deoxyadenosine, guanosine, deoxyguanosine, adenine, or guanine by mutant U- and mutant U-UR- is identical with that in the parental strain. Uridine is transported by E. coli B as intact uridine. In addition, extracellular uridine is also rapidly cleaved to uracil and the ribose moiety. The latter is transported into the cells, whereas uracil appears in the medium and is transported by a separate uracil transport system. The entry of the ribose moiety of uridine is fast relative to the uracil and uridine transport processes. The Km values and the inhibitory effects of heterologous nucleosides for the transport of uridine and the ribose moiety of uridine are similar. Studies of cytidine uptake in the parental and mutant strains provide evidence that cytidine is transported by two independent systems, one of which is the same as that involved in the transport of intact uridine. Uridine inhibits but is not transported by the other system for cytidine transport. Evidence for the above conclusions was based on comparisons of the characteristics of [2-14C]uridine, [U-14C]uridine, and [2-14C]cytidine transport using E. coli B and the three transport mutants under conditions which measure initial rates. The nature of the inhibitory effects of heterologous nucleosides on the uridine transport processes and identification of extracellular components from radioactive uridine provides supportive data for the conclusions.
分离出了大肠杆菌B的三个突变体,它们在尿苷和尿嘧啶转运系统的组成部分存在缺陷,并用于研究尿苷转运机制。突变体U-是从对77微摩尔5-氟尿嘧啶有抗性的培养物中分离出来的。从突变体U-的培养物中分离出的突变体U-UR-,对770微摩尔5-氟尿嘧啶和750微摩尔腺苷有抗性。突变体NUC-对80微摩尔showdomycin有抗性,且此前已有报道。大肠杆菌B及其突变体的尿苷转运特性提供了支持以下结论的数据。突变体U-和突变体U-UR-对腺苷、脱氧腺苷、鸟苷、脱氧鸟苷、腺嘌呤或鸟嘌呤的转运与亲本菌株相同。大肠杆菌B将尿苷作为完整的尿苷进行转运。此外,细胞外的尿苷也会迅速裂解为尿嘧啶和核糖部分。后者被转运到细胞内,而尿嘧啶则出现在培养基中,并通过一个独立的尿嘧啶转运系统进行转运。相对于尿嘧啶和尿苷的转运过程,尿苷核糖部分的进入速度较快。异源核苷对尿苷和尿苷核糖部分转运的Km值及抑制作用相似。对亲本菌株和突变体菌株中胞苷摄取的研究提供了证据,表明胞苷通过两个独立的系统进行转运,其中一个与完整尿苷转运所涉及的系统相同。尿苷对另一个胞苷转运系统有抑制作用,但不被该系统转运。上述结论的证据基于在测量初始速率的条件下使用大肠杆菌B和三个转运突变体对[2-14C]尿苷、[U-14C]尿苷和[2-14C]胞苷转运特性的比较。异源核苷对尿苷转运过程的抑制作用性质以及从放射性尿苷中鉴定细胞外成分,为这些结论提供了支持性数据。